Campisi, Edmondo
Rinaudo, C. Daniela
Donati, Claudio
Barucco, Mara
Torricelli, Giulia
Edwards, Morven S.
Baker, Carol J.
Margarit, Imma
Rosini, Roberto
Article History
Received: 7 March 2016
Accepted: 21 June 2016
First Online: 14 July 2016
Competing interests
: This work was supported by internal funding from Novartis Vaccines (now GSK Vaccines S.r.l.). C.D.R., G.T., I.M. and R.R. are employees of GSK Vaccines. The GSK authors confirm that the funder provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. C.J.B is a consultant to Pfizer, Inc. and CureVac. M.S.E receives research funds from Pfizer, Inc. DEVANI strain collection was supported by the European Commission Seventh Framework (Grant agreement number 200481, DEVANI program).